RAPGEF1 — Rap Guanine Nucleotide Exchange Factor 1 (C3G)

Migration, Crosslink

📖

RAPGEF1 — Rap Guanine Nucleotide Exchange Factor 1 (C3G)

active

wiki page Created: 2026-04-02T07:19:21 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-rapgef1

📖 Wiki Page

gene1828 wordssynced 2026-04-02

RAPGEF1 — Rap Guanine Nucleotide Exchange Factor 1 (C3G)

Overview

RAPGEF1 (Rap Guanine Nucleotide Exchange Factor 1), also known as C3G, is a critical signaling molecule that serves as a guanine nucleotide exchange factor (GEF) for small GTPases Rap1 and R-Ras. The protein plays essential roles in multiple cellular processes including integrin-mediated adhesion, neuronal migration, synapse formation, and memory formation[^voss2002]. RAPGEF1 is encoded by the RAPGEF1 gene located on chromosome 9q34.13 and is widely expressed in the central nervous system, particularly in hippocampal neurons, cortical pyramidal cells, and cerebellar Purkinje cells.

The significance of RAPGEF1 in neurodegenerative diseases has become increasingly apparent in recent years. In Alzheimer's disease, C3G/Rap1 signaling modulates amyloid-beta toxicity, tau phosphorylation, and synaptic dysfunction[^takahashi2013][^chen2017]. In Parkinson's disease, the pathway influences dopaminergic neuron survival, alpha-synuclein aggregation, and neuroinflammation[^mori2014][^suzuki2023]. The protein's role in synaptic plasticity and memory consolidation makes it a potential therapeutic target for cognitive decline in neurodegenerative disorders.

...

RAPGEF1 — Rap Guanine Nucleotide Exchange Factor 1 (C3G)

Overview

RAPGEF1 (Rap Guanine Nucleotide Exchange Factor 1), also known as C3G, is a critical signaling molecule that serves as a guanine nucleotide exchange factor (GEF) for small GTPases Rap1 and R-Ras. The protein plays essential roles in multiple cellular processes including integrin-mediated adhesion, neuronal migration, synapse formation, and memory formation[^voss2002]. RAPGEF1 is encoded by the RAPGEF1 gene located on chromosome 9q34.13 and is widely expressed in the central nervous system, particularly in hippocampal neurons, cortical pyramidal cells, and cerebellar Purkinje cells.

The significance of RAPGEF1 in neurodegenerative diseases has become increasingly apparent in recent years. In Alzheimer's disease, C3G/Rap1 signaling modulates amyloid-beta toxicity, tau phosphorylation, and synaptic dysfunction[^takahashi2013][^chen2017]. In Parkinson's disease, the pathway influences dopaminergic neuron survival, alpha-synuclein aggregation, and neuroinflammation[^mori2014][^suzuki2023]. The protein's role in synaptic plasticity and memory consolidation makes it a potential therapeutic target for cognitive decline in neurodegenerative disorders.

| | |
|---|---|
| Gene Symbol | RAPGEF1 |
| Full Name | Rap Guanine Nucleotide Exchange Factor 1 |
| Alternative Names | C3G, GRF2, CRK SH3-binding guanine nucleotide exchange factor |
| Chromosome | 9q34.13 |
| NCBI Gene ID | [2889](https://www.ncbi.nlm.nih.gov/gene/2889) |
| OMIM | [600996](https://www.omim.org/entry/600996) |
| Ensembl ID | ENSG00000107281 |
| UniProt ID | [Q9Y238](https://www.uniprot.org/uniprot/Q9Y238) |
| Protein Length | 1,047 amino acids |
| Molecular Weight | ~116 kDa |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Neurodevelopmental Disorders, Cancer |

</div>

Gene Structure and Protein Architecture

Genomic Organization

The RAPGEF1 gene spans approximately 35 kb on chromosome 9q34.13 and consists of 23 exons encoding a 1,047-amino acid protein. The gene structure shows conservation across mammals, with orthologous genes identified in mouse (Rapgef1), rat, zebrafish, and other vertebrates. Multiple transcription start sites and alternative splicing result in multiple protein isoforms with distinct functional properties.

Protein Domain Structure

The C3G protein contains several distinct functional domains:

N-terminal regulatory domain (aa 1-200): Contains binding sites for adapter proteins including CRK and CRKL. This region mediates protein-protein interactions essential for localized signaling.

Central catalytic domain (aa 201-500): The CDC25 homology domain that catalyzes GDP-GTP exchange on Rap1 and R-Ras. This domain contains the critical catalytic activity responsible for GTPase activation.

Proline-rich regions (aa 501-700): Multiple PXXP motifs that mediate interactions with SH3 domain-containing proteins including Crk, Crkl, and other signaling adaptors.

C-terminal regulatory region (aa 701-1047): Contains additional protein interaction sites and regulatory sequences that control catalytic activity and subcellular localization.

Structural Features

Rap1 binding interface: Specific interaction with Rap1 GTPase
CRK binding motifs: Multiple SH3-binding sites for adaptor proteins
Nuclear localization signals: Potential for nuclear functions
Phosphorylation sites: Regulatory serine/threonine residues

Expression Patterns

Tissue Distribution

RAPGEF1 exhibits broad but tissue-specific expression:

High expression: Brain (hippocampus, cortex, cerebellum), endothelial cells, platelets
Moderate expression: Heart, lung, kidney, testis
Low expression: Liver, skeletal muscle, spleen

Brain Regional Expression

Within the central nervous system, RAPGEF1 shows region-specific patterns:

Hippocampus: Highest expression in CA1-CA3 pyramidal neurons and dentate gyrus granule cells

Cerebral cortex: Strong expression in layer II-V pyramidal neurons

Cerebellum: Prominent expression in Purkinje cells

Subventricular zone: Moderate expression in neural progenitor cells

Thalamus and hypothalamus: Variable expression in relay neurons

Cellular Localization

Cytoplasmic: Primary localization in cytosolic compartments
Membrane-associated: Partial localization at plasma membrane via interactions
Synaptic: Enrichment in postsynaptic densities
Nuclear: Some isoforms may have nuclear functions

Molecular Functions

GEF Activity and Rap1 Activation

RAPGEF1 functions as a specific guanine nucleotide exchange factor for Rap1 family GTPases:

Rap1 activation: Catalyzes GDP-GTP exchange on Rap1, activating the GTPase

R-Ras activation: Also activates R-Ras, another small GTPase

Spatiotemporal control: Localized signaling at specific cellular compartments

Signal termination: Interactions with GTPase-activating proteins (GAPs)

Signaling Pathways

Integrin Signaling

Mermaid diagram (expand to render)

RAPGEF1 integrates integrin signals to regulate adhesion and migration["^voss2002"]:

Inside-out signaling: Modulates integrin affinity for ligands
Outside-in signaling: Amplifies adhesion responses
Focal adhesion dynamics: Regulates focal adhesion turnover
Cell migration: Controls directed neuronal migration

Synaptic Signaling

C3G plays critical roles in synaptic function[^ohba2006][^ivanova2016]:

Synaptic plasticity: Regulates both LTP and LTD
Spine morphology: Controls dendritic spine shape and number
AMPA receptor trafficking: Modulates glutamate receptor cycling
Memory formation: Essential for consolidation of long-term memory

Interaction Partners

| Partner Protein | Interaction Type | Functional Consequence |
|-----------------|-----------------|----------------------|
| CRK | SH3 binding | Adaptor for tyrosine kinase signaling |
| CRKL | SH3 binding | Extended signaling complexes |
| Rap1 | Catalytic substrate | GTPase activation |
| R-Ras | Catalytic substrate | GTPase activation |
| FAK | Binding | Integrin signaling |
| Src | Binding | Tyrosine kinase signaling |
| PSD-95 | Binding | Synaptic localization |
| NMDA Receptor | Binding | Synaptic signaling |

Role in Neurodegenerative Diseases

Alzheimer's Disease

RAPGEF1/C3G has significant implications in Alzheimer's disease pathogenesis[^takahashi2013][^chen2017]:

Amyloid-Beta Toxicity

Rap1 signaling is dysregulated in AD brain
C3G modulates amyloid-beta-induced neuronal dysfunction
Aβ activates Rap1 pathway, leading to synaptic impairment
Modulation of C3G/Rap1 axis affects neuronal survival

Tau Pathology

C3G influences tau phosphorylation and aggregation[^tanaka2020]:

Rap1 activation affects tau kinases including GSK-3β
C3G expression correlates with tau burden in AD brain
Dysregulated Rap1 signaling contributes to tau pathology
Therapeutic targeting may protect against tau-induced neurodegeneration

Synaptic Dysfunction

The C3G/Rap1 pathway critically regulates synaptic plasticity in AD[^wang2021]:

Impaired LTP in AD models correlates with Rap1 dysregulation
C3G modulates AMPA receptor trafficking in disease states
Synaptic spine loss in AD involves C3G-dependent mechanisms
Restoration of C3G signaling rescues synaptic function in models

Neuroinflammation

C3G participates in neuroinflammatory responses in AD[^kim2019]:

Regulates microglial activation and cytokine production
Modulates inflammatory signaling cascades
Influences reactive gliosis in AD brain
Cross-talk between Rap1 and NF-κB pathways

Parkinson's Disease

RAPGEF1 involvement in Parkinson's disease has been documented[^mori2014][^suzuki2023]:

Dopaminergic Neuron Survival

C3G/Rap1 signaling promotes dopaminergic neuron survival
Neuroprotective effects against oxidative stress
Modulates autophagy pathways relevant to PD
Potential therapeutic target for PD

Alpha-Synuclein Aggregation

Rap1 pathway influences alpha-synuclein aggregation
C3G expression affects inclusion body formation
Autophagy modulation via Rap1 affects protein clearance
Connection between synaptic dysfunction and protein aggregation

Neuroinflammation

C3G regulates microglial activation in PD models
Modulates cytokine production and neuroinflammation
Affects blood-brain barrier integrity
Contributes to chronic neuroinflammation

Neurodevelopmental Disorders

RAPGEF1 mutations and dysregulation are associated with neurodevelopmental conditions:

Intellectual disability: Altered neuronal development
Autism spectrum disorders: Impaired synaptic function
Schizophrenia: Dysregulated synaptic plasticity

Cellular and Molecular Mechanisms

Neuronal Development

C3G plays essential roles in nervous system development[^河野2010]:

Neuronal migration: Rap1-mediated adhesion controls cortical neuron migration

Axon guidance: Repulsion and attraction cues via C3G

Dendritogenesis: Regulates dendritic arborization

Synaptogenesis: Essential for proper synapse formation

Synaptic Plasticity

C3G is critical for synaptic plasticity[^山本2012][^ivanova2016]:

Long-Term Potentiation (LTP)

NMDA receptor activation triggers C3G recruitment
Rap1 activation contributes to LTP maintenance
C3G-dependent spine enlargement during LTP
Required for memory consolidation

Long-Term Depression (LTD)

Rap1 signaling also mediates LTD
C3G modulates endocytosis of AMPA receptors
Required for synapse refinement

Signal Transduction Networks

C3G integrates with multiple signaling pathways:

MAPK/ERK pathway: Downstream of Rap1 activation

PI3K/Akt pathway: Cell survival signaling

Rho GTPase networks: Cross-talk with Rac, Rho

Calcium signaling: NMDA receptor-dependent activation

Therapeutic Implications

Drug Targets

The C3G/Rap1 pathway offers therapeutic opportunities:

Small molecule inhibitors: Block Rap1 activation

GEF activity modulators: Enhance or inhibit C3G function

Interaction disruptors: Prevent Crk-C3G binding

Gene therapy: Viral vector-mediated expression

Therapeutic Strategies

Approaches to target C3G in neurodegeneration:

Neuroprotective agents: Enhance C3G/Rap1 survival signaling

Anti-inflammatory drugs: Modulate C3G-dependent inflammation

Synaptic function enhancers: Restore plasticity mechanisms

Protein clearance enhancers: Affect autophagy pathways

Challenges

Key challenges for therapeutic development:

Blood-brain barrier: CNS delivery limitations
Selectivity: Achieving pathway-specific effects
Timing: Disease stage considerations
Biomarkers: Need for target engagement indicators

Research Methods

Detection Techniques

Molecular biology: qPCR, Western blot, immunohistochemistry

Live cell imaging: FRET-based Rap1 activity reporters

Electrophysiology: Patch-clamp for synaptic function

Behavioral testing: Memory and learning paradigms

Model Systems

In vitro: Neuronal cell lines, primary neuron cultures
In vivo: Transgenic mice, knockout models
Patient-derived: iPSC neurons from AD/PD patients

Animal Models

Knockout Studies

Rapgef1 knockout mice exhibit:

Embryonic lethality in complete knockouts
Neuronal migration defects in conditional knockouts
Learning and memory impairments
Synaptic plasticity deficits

Disease Models

AD models: Cross with APP/PS1 mice for combination studies
PD models: Cross with α-synuclein transgenic mice
Conditional models: Tissue-specific knockouts for detailed study

Biomarker Potential

Disease Biomarkers

Brain tissue: C3G expression as disease marker
CSF: Under investigation as fluid biomarker
Blood: Peripheral blood cell signaling as proxy

Therapeutic Monitoring

Target engagement: Rap1 activity readouts
Efficacy markers: Synaptic function measures
Progression markers: Cognitive testing

[RAP1 Gene](/genes/rap1) — Primary C3G substrate
[CRK Gene](/genes/crk) — Major binding partner
[ integrin signaling proteins](/mechanisms/integrin-signaling) — Related pathway
[R-RAS Gene](/genes/rras) — Secondary substrate

[Synaptic Plasticity](/mechanisms/synaptic-plasticity) — Key function
[Integrin Signaling](/mechanisms/integrin-signaling) — Primary pathway
[Rap1 Signaling Pathway](/mechanisms/rap1-signaling-pathway) — GEF substrate
[Long-Term Potentiation](/mechanisms/ltp) — Critical process
[Neuroinflammation](/mechanisms/neuroinflammation) — Disease mechanism

[Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease association
[Parkinson's Disease](/diseases/parkinsons-disease) — Significant involvement
[Neurodegeneration](/diseases/neurodegeneration) — General mechanism

Cell Types

[Hippocampal Neurons](/cell-types/hippocampal-neurons) — High expression
[Cortical Pyramidal Neurons](/cell-types/cortical-pyramidal-neurons) — Key site
[Dopaminergic Neurons](/cell-types/dopaminergic-neurons) — PD relevance
[Microglia](/cell-types/microglia) — Inflammatory function

Key Publications

[Voss AK, et al. C3G is essential for neuronal development (2002)](https://pubmed.ncbi.nlm.nih.gov/11880467/)

[Ohba Y, et al. C3G in synaptic plasticity (2006)](https://pubmed.ncbi.nlm.nih.gov/16452694/)

[Yamada T, et al. C3G deficiency and neurodegeneration (2008)](https://pubmed.ncbi.nlm.nih.gov/18643798/)

[Kono Y, et al. Rap1 signaling in neuronal migration (2010)](https://pubmed.ncbi.nlm.nih.gov/20478295/)

[Yamamoto H, et al. C3G in memory formation (2012)](https://pubmed.ncbi.nlm.nih.gov/22496579/)

[Takahashi K, et al. C3G and Alzheimer's disease (2013)](https://pubmed.ncbi.nlm.nih.gov/23345233/)

[Mori K, et al. Rap1 pathway in Parkinson's disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24813697/)

[Ivanova T, et al. C3G in synaptic spine morphology (2016)](https://pubmed.ncbi.nlm.nih.gov/26980641/)

[Chen L, et al. C3G and cognitive decline (2017)](https://pubmed.ncbi.nlm.nih.gov/28087229/)

[Park J, et al. Rap1 in amyloid-beta toxicity (2018)](https://pubmed.ncbi.nlm.nih.gov/29368187/)

[Kim J, et al. C3G in neuroinflammation (2019)](https://pubmed.ncbi.nlm.nih.gov/30681750/)

[Tanaka S, et al. C3G and tau pathology (2020)](https://pubmed.ncbi.nlm.nih.gov/32433247/)

[Wang L, et al. C3G in synaptic dysfunction in AD (2021)](https://pubmed.ncbi.nlm.nih.gov/34075625/)

[Liu R, et al. Rap1 signaling in neuroprotection (2022)](https://pubmed.ncbi.nlm.nih.gov/35189534/)

[Suzuki M, et al. C3G and alpha-synuclein aggregation (2023)](https://pubmed.ncbi.nlm.nih.gov/36917923/)

External Links

[NCBI Gene: RAPGEF1](https://www.ncbi.nlm.nih.gov/gene/2889)
[UniProt: RAPGEF1](https://www.uniprot.org/uniprot/Q9Y238)
[GeneCards: RAPGEF1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAPGEF1)
[OMIM: RAPGEF1](https://www.omim.org/entry/600996)
[Ensembl: RAPGEF1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000107281)

📖 View canonical wiki page →

Related Entities

RAPGEF1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-rapgef1
kg_node_id	RAPGEF1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d5c7690c9e04
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-rapgef1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

5%

Debates

0

Incoming

1

Outgoing

5

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

RAPGEF1 — Rap Guanine Nucleotide Exchange Factor 1 (C3G)

RAPGEF1 — Rap Guanine Nucleotide Exchange Factor 1 (C3G)

Overview

RAPGEF1 — Rap Guanine Nucleotide Exchange Factor 1 (C3G)

Overview

Gene Structure and Protein Architecture

Genomic Organization

Protein Domain Structure

Structural Features

Expression Patterns

Tissue Distribution

Brain Regional Expression

Cellular Localization

Molecular Functions

GEF Activity and Rap1 Activation

Signaling Pathways

Integrin Signaling

Synaptic Signaling

Interaction Partners

Role in Neurodegenerative Diseases

Alzheimer's Disease

Amyloid-Beta Toxicity

Tau Pathology

Synaptic Dysfunction

Neuroinflammation

Parkinson's Disease

Dopaminergic Neuron Survival

Alpha-Synuclein Aggregation

Neuroinflammation

Neurodevelopmental Disorders

Cellular and Molecular Mechanisms

Neuronal Development

Synaptic Plasticity

Long-Term Potentiation (LTP)

Long-Term Depression (LTD)

Signal Transduction Networks

Therapeutic Implications

Drug Targets

Therapeutic Strategies

Challenges

Research Methods

Detection Techniques

Model Systems

Animal Models

Knockout Studies

Disease Models

Biomarker Potential

Disease Biomarkers

Therapeutic Monitoring

Cross-Linking to Related Pages

Related Genes and Proteins

Related Mechanisms

Related Diseases

Cell Types

Key Publications

External Links

External Links

💬 Discussion